John Docherty - Aug 29, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
President, Director
Signature
/John Docherty/
Stock symbol
LEXX
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/29/2022, 05:26 PM
Previous filing
Sep 2, 2021
Next filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 54.1K Aug 29, 2022 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +30K +46.39% $0.00 94.7K Aug 29, 2022 Common Shares 30K $2.91 Direct
holding LEXX Stock Options 13.3K Aug 29, 2022 Common Shares 13.3K $9.60 Direct
holding LEXX Stock Options 31.3K Aug 29, 2022 Common Shares 18K $5.31 Direct
holding LEXX Stock Options 49.7K Aug 29, 2022 Common Shares 18.3K $7.08 Direct
holding LEXX Stock Options 64.7K Aug 29, 2022 Common Shares 15K $6.23 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.